SCHEMBL18575

SCHEMBL18575

O=C1CN(C[C@H]2CN(S(=O)(=O)c3cccs3)CCN2c2ccc(C(F)(F)F)cc2)CCN1

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 15/20 0.61
GCK P35557 5/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17898 0.92 GCK (0.73) GCKRGCK
SCHEMBL17473 0.92 GCK (0.73) GCKRGCK
SCHEMBL18180 0.92 GCK (0.73) GCKRGCK
SCHEMBL12090042 0.91 GCK (0.62) GCKRGCK
SCHEMBL18596 0.84 GCKR (0.60) GCKRGCK
SCHEMBL19030 0.84 GCKR (0.60) GCKRGCK
SCHEMBL19995 0.83 GCKR (0.59) GCKRGCK
SCHEMBL18885 0.82 GCK (0.58) GCKRGCK
SCHEMBL12093316 0.82 GCKR (0.41) GCKRGCK
SCHEMBL12078575 0.78 GCK (0.71) GCKRGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431563-B2 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes AMGEN INC. (US) 2013-04-30 US disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed